ID   CENPJ_HUMAN             Reviewed;        1338 AA.
AC   Q9HC77; Q2KHM6; Q5JPD5; Q5T6R5; Q96KS5; Q9C067;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2005, sequence version 2.
DT   07-APR-2021, entry version 163.
DE   RecName: Full=Centromere protein J;
DE            Short=CENP-J;
DE   AltName: Full=Centrosomal P4.1-associated protein;
DE   AltName: Full=LAG-3-associated protein;
DE   AltName: Full=LYST-interacting protein 1;
GN   Name=CENPJ; Synonyms=CPAP, LAP, LIP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH EPB41 AND GAMMA-TUBULIN.
RX   PubMed=11003675; DOI=10.1128/mcb.20.20.7813-7825.2000;
RA   Hung L.-Y., Tang C.J., Tang T.K.;
RT   "Protein 4.1 R-135 interacts with a novel centrosomal protein (CPAP) which
RT   is associated with the gamma-tubulin complex.";
RL   Mol. Cell. Biol. 20:7813-7825(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lymph node;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 967-1338 (ISOFORM 1).
RA   Andreae S., Triebel P.F.;
RT   "LAP, a lymphocyte activation gene-3-associated protein that binds to a
RT   repeated EP motif in the intracellular region of LAG-3 may participate in
RT   the down-regulation of the CD3/TCR activation pathway.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1142-1338 (ISOFORM 1), AND INTERACTION WITH
RP   LYST.
RX   PubMed=11984006; DOI=10.1007/bf03402003;
RA   Tchernev V.T., Mansfield T.A., Giot L., Kumar A.M., Nandabalan K., Li Y.,
RA   Mishra V.S., Detter J.C., Rothberg J.M., Wallace M.R., Southwick F.S.,
RA   Kingsmore S.F.;
RT   "The Chediak-Higashi protein interacts with SNARE complex and signal
RT   transduction proteins.";
RL   Mol. Med. 8:56-64(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [9]
RP   FUNCTION IN MICROTUBULE DESTABILIZATION.
RX   PubMed=15047868; DOI=10.1091/mbc.e04-02-0121;
RA   Hung L.-Y., Chen H.-L., Chang C.-W., Li B.-R., Tang T.K.;
RT   "Identification of a novel microtubule-destabilizing motif in CPAP that
RT   binds to tubulin heterodimers and inhibits microtubule assembly.";
RL   Mol. Biol. Cell 15:2697-2706(2004).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17681131; DOI=10.1016/j.devcel.2007.07.002;
RA   Kleylein-Sohn J., Westendorf J., Le Clech M., Habedanck R., Stierhof Y.-D.,
RA   Nigg E.A.;
RT   "Plk4-induced centriole biogenesis in human cells.";
RL   Dev. Cell 13:190-202(2007).
RN   [11]
RP   TUBULIN-BINDING.
RX   PubMed=19131341; DOI=10.1074/jbc.m808249200;
RA   Cormier A., Clement M.J., Knossow M., Lachkar S., Savarin P., Toma F.,
RA   Sobel A., Gigant B., Curmi P.A.;
RT   "The PN2-3 domain of centrosomal P4.1-associated protein implements a novel
RT   mechanism for tubulin sequestration.";
RL   J. Biol. Chem. 284:6909-6917(2009).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-589 AND SER-595, AND
RP   MUTAGENESIS OF SER-589 AND SER-595.
RX   PubMed=20531387; DOI=10.1038/emboj.2010.118;
RA   Chang J., Cizmecioglu O., Hoffmann I., Rhee K.;
RT   "PLK2 phosphorylation is critical for CPAP function in procentriole
RT   formation during the centrosome cycle.";
RL   EMBO J. 29:2395-2406(2010).
RN   [13]
RP   INVOLVEMENT IN SCKL4.
RX   PubMed=20522431; DOI=10.1136/jmg.2009.076646;
RA   Al-Dosari M.S., Shaheen R., Colak D., Alkuraya F.S.;
RT   "Novel CENPJ mutation causes Seckel syndrome.";
RL   J. Med. Genet. 47:411-414(2010).
RN   [14]
RP   INTERACTION WITH CEP152.
RX   PubMed=20852615; DOI=10.1038/nature09445;
RA   Dzhindzhev N.S., Yu Q.D., Weiskopf K., Tzolovsky G., Cunha-Ferreira I.,
RA   Riparbelli M., Rodrigues-Martins A., Bettencourt-Dias M., Callaini G.,
RA   Glover D.M.;
RT   "Asterless is a scaffold for the onset of centriole assembly.";
RL   Nature 467:714-718(2010).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH STIL, FORMATION OF A
RP   COMPLEX WITH STIL AND SASS8, AND CHARACTERIZATION OF VARIANT MCPH6
RP   VAL-1235.
RX   PubMed=22020124; DOI=10.1038/emboj.2011.378;
RA   Tang C.J., Lin S.Y., Hsu W.B., Lin Y.N., Wu C.T., Lin Y.C., Chang C.W.,
RA   Wu K.S., Tang T.K.;
RT   "The human microcephaly protein STIL interacts with CPAP and is required
RT   for procentriole formation.";
RL   EMBO J. 30:4790-4804(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-759, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-260; SER-316 AND SER-540, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   INTERACTION WITH STIL.
RX   PubMed=25385835; DOI=10.15252/embj.201488979;
RA   Shiratsuchi G., Takaoka K., Ashikawa T., Hamada H., Kitagawa D.;
RT   "RBM14 prevents assembly of centriolar protein complexes and maintains
RT   mitotic spindle integrity.";
RL   EMBO J. 34:97-114(2015).
RN   [19]
RP   FUNCTION.
RX   PubMed=27185865; DOI=10.1242/jcs.186338;
RA   Chang C.W., Hsu W.B., Tsai J.J., Tang C.J., Tang T.K.;
RT   "CEP295 interacts with microtubules and is required for centriole
RT   elongation.";
RL   J. Cell Sci. 129:2501-2513(2016).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 311-422 IN COMPLEX WITH TUBULIN
RP   HETERODIMER AND DARPIN D1, SELF-ASSOCIATION, FUNCTION, AND MUTAGENESIS OF
RP   PHE-338; GLU-339; TYR-341; PHE-375; LYS-377; ARG-378 AND PHE-385.
RX   PubMed=27219064; DOI=10.1016/j.devcel.2016.04.024;
RA   Sharma A., Aher A., Dynes N.J., Frey D., Katrukha E.A., Jaussi R.,
RA   Grigoriev I., Croisier M., Kammerer R.A., Akhmanova A., Gonczy P.,
RA   Steinmetz M.O.;
RT   "Centriolar CPAP/SAS-4 imparts slow processive microtubule growth.";
RL   Dev. Cell 37:362-376(2016).
RN   [21] {ECO:0007744|PDB:5EIB}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 372-394, FUNCTION, AND
RP   MUTAGENESIS OF GLU-343; GLU-344 AND PHE-375.
RX   PubMed=27306797; DOI=10.1038/ncomms11874;
RA   Zheng X., Ramani A., Soni K., Gottardo M., Zheng S., Ming Gooi L., Li W.,
RA   Feng S., Mariappan A., Wason A., Widlund P., Pozniakovsky A., Poser I.,
RA   Deng H., Ou G., Riparbelli M., Giuliano C., Hyman A.A., Sattler M.,
RA   Gopalakrishnan J., Li H.;
RT   "Molecular basis for CPAP-tubulin interaction in controlling centriolar and
RT   ciliary length.";
RL   Nat. Commun. 7:11874-11874(2016).
RN   [22]
RP   VARIANT MCPH6 VAL-1235.
RX   PubMed=15793586; DOI=10.1038/ng1539;
RA   Bond J., Roberts E., Springell K., Lizarraga S.B., Scott S., Higgins J.,
RA   Hampshire D.J., Morrison E.E., Leal G.F., Silva E.O., Costa S.M.R.,
RA   Baralle D., Raponi M., Karbani G., Rashid Y., Jafri H., Bennett C.,
RA   Corry P., Walsh C.A., Woods C.G.;
RT   "A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain
RT   size.";
RL   Nat. Genet. 37:353-355(2005).
RN   [23]
RP   ERRATUM OF PUBMED:15793586.
RA   Bond J., Roberts E., Springell K., Lizarraga S.B., Scott S., Higgins J.,
RA   Hampshire D.J., Morrison E.E., Leal G.F., Silva E.O., Costa S.M.R.,
RA   Baralle D., Raponi M., Karbani G., Rashid Y., Jafri H., Bennett C.,
RA   Corry P., Walsh C.A., Woods C.G.;
RL   Nat. Genet. 37:555-555(2005).
CC   -!- FUNCTION: Plays an important role in cell division and centrosome
CC       function by participating in centriole duplication (PubMed:17681131,
CC       PubMed:20531387). Inhibits microtubule nucleation from the centrosome.
CC       Involved in the regulation of slow processive growth of centriolar
CC       microtubules. Acts as microtubule plus-end tracking protein that
CC       stabilizes centriolar microtubules and inhibits microtubule
CC       polymerization and extension from the distal ends of centrioles
CC       (PubMed:15047868, PubMed:27219064, PubMed:27306797). Required for
CC       centriole elongation and for STIL-mediated centriole amplification
CC       (PubMed:22020124). Required for the recruitment of CEP295 to the
CC       proximal end of new-born centrioles at the centriolar microtubule wall
CC       during early S phase in a PLK4-dependent manner (PubMed:27185865). May
CC       be involved in the control of centriolar-microtubule growth by acting
CC       as a regulator of tubulin release (PubMed:27306797).
CC       {ECO:0000269|PubMed:15047868, ECO:0000269|PubMed:17681131,
CC       ECO:0000269|PubMed:20531387, ECO:0000269|PubMed:22020124,
CC       ECO:0000269|PubMed:27185865, ECO:0000269|PubMed:27219064,
CC       ECO:0000305|PubMed:27306797}.
CC   -!- SUBUNIT: Forms homodimers (PubMed:27219064). Associates with
CC       microtubules plus ends; binds to beta-tublin subunits exposed on
CC       microtubule outer surface at its distal tip; also associates with
CC       microtubule lattice (PubMed:19131341, PubMed:27219064,
CC       PubMed:27306797). Associated with the gamma-tubulin complex. Interacts
CC       with the head domain of EPB41 (PubMed:11003675). Interacts with LYST
CC       (PubMed:11984006). Interacts with CEP152 (via C-terminus)
CC       (PubMed:20852615). Interacts with STIL (PubMed:22020124,
CC       PubMed:25385835). Forms a complex with STIL and SASS6
CC       (PubMed:22020124). {ECO:0000269|PubMed:11003675,
CC       ECO:0000269|PubMed:11984006, ECO:0000269|PubMed:20852615,
CC       ECO:0000269|PubMed:22020124, ECO:0000269|PubMed:25385835,
CC       ECO:0000269|PubMed:27219064, ECO:0000269|PubMed:27306797}.
CC   -!- INTERACTION:
CC       Q9HC77; Q9P287: BCCIP; NbExp=3; IntAct=EBI-946194, EBI-711154;
CC       Q9HC77; Q9HC77: CENPJ; NbExp=3; IntAct=EBI-946194, EBI-946194;
CC       Q9HC77; Q66GS9: CEP135; NbExp=8; IntAct=EBI-946194, EBI-1046993;
CC       Q9HC77; Q96RK0: CIC; NbExp=2; IntAct=EBI-946194, EBI-945857;
CC       Q9HC77; Q5VTD9: GFI1B; NbExp=2; IntAct=EBI-946194, EBI-946212;
CC       Q9HC77; Q9NYY3: PLK2; NbExp=3; IntAct=EBI-946194, EBI-721354;
CC       Q9HC77; Q15468: STIL; NbExp=15; IntAct=EBI-946194, EBI-7488405;
CC       Q9HC77; O95271: TNKS; NbExp=4; IntAct=EBI-946194, EBI-1105254;
CC       Q9HC77; P61981: YWHAG; NbExp=3; IntAct=EBI-946194, EBI-359832;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000269|PubMed:11003675,
CC       ECO:0000269|PubMed:14654843, ECO:0000269|PubMed:20531387}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome, centriole
CC       {ECO:0000269|PubMed:17681131, ECO:0000269|PubMed:20531387,
CC       ECO:0000269|PubMed:22020124}. Note=Localized within the center of
CC       microtubule asters (PubMed:11003675). During centriole biogenesis, it
CC       is concentrated within the proximal lumen of both parental centrioles
CC       and procentrioles (PubMed:17681131). {ECO:0000269|PubMed:11003675,
CC       ECO:0000269|PubMed:17681131}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HC77-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HC77-2; Sequence=VSP_056831, VSP_056832;
CC   -!- PTM: Phosphorylation at Ser-589 and Ser-595 by PLK2 is required for
CC       procentriole formation and centriole elongation. Phosphorylation by
CC       PLK2 oscillates during the cell cycle: it increases at G1/S transition
CC       and decreases during the exit from mitosis. Phosphorylation at Ser-595
CC       is also mediated by PLK4 but is not a critical step in PLK4 function in
CC       procentriole assembly. {ECO:0000269|PubMed:20531387}.
CC   -!- DISEASE: Microcephaly 6, primary, autosomal recessive (MCPH6)
CC       [MIM:608393]: A disease defined as a head circumference more than 3
CC       standard deviations below the age-related mean. Brain weight is
CC       markedly reduced and the cerebral cortex is disproportionately small.
CC       Despite this marked reduction in size, the gyral pattern is relatively
CC       well preserved, with no major abnormality in cortical architecture.
CC       Affected individuals are mentally retarded. Primary microcephaly is
CC       further defined by the absence of other syndromic features or
CC       significant neurological deficits due to degenerative brain disorder.
CC       {ECO:0000269|PubMed:15793586, ECO:0000269|PubMed:22020124}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Seckel syndrome 4 (SCKL4) [MIM:613676]: A rare autosomal
CC       recessive disorder characterized by proportionate dwarfism of prenatal
CC       onset associated with low birth weight, growth retardation, severe
CC       microcephaly with a bird-headed like appearance, and mental
CC       retardation. {ECO:0000269|PubMed:20522431}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TCP10 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH24209.3; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF139625; AAG21074.1; -; mRNA.
DR   EMBL; AL833182; CAI46195.1; -; mRNA.
DR   EMBL; AL354798; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08354.1; -; Genomic_DNA.
DR   EMBL; BC024209; AAH24209.3; ALT_INIT; mRNA.
DR   EMBL; BC113110; AAI13111.1; -; mRNA.
DR   EMBL; BC113662; AAI13663.1; -; mRNA.
DR   EMBL; BC113664; AAI13665.1; -; mRNA.
DR   EMBL; AJ303006; CAC80028.1; -; mRNA.
DR   EMBL; AF141337; AAG49440.1; -; mRNA.
DR   CCDS; CCDS9310.1; -. [Q9HC77-1]
DR   RefSeq; NP_060921.3; NM_018451.4. [Q9HC77-1]
DR   PDB; 5EIB; X-ray; 2.10 A; F=372-394.
DR   PDB; 5ITZ; X-ray; 2.20 A; D=311-422.
DR   PDBsum; 5EIB; -.
DR   PDBsum; 5ITZ; -.
DR   BMRB; Q9HC77; -.
DR   SMR; Q9HC77; -.
DR   BioGRID; 120939; 156.
DR   ComplexPortal; CPX-1159; CPAP-STIL complex.
DR   DIP; DIP-49904N; -.
DR   IntAct; Q9HC77; 137.
DR   MINT; Q9HC77; -.
DR   STRING; 9606.ENSP00000371308; -.
DR   iPTMnet; Q9HC77; -.
DR   PhosphoSitePlus; Q9HC77; -.
DR   BioMuta; CENPJ; -.
DR   DMDM; 62899891; -.
DR   EPD; Q9HC77; -.
DR   jPOST; Q9HC77; -.
DR   MassIVE; Q9HC77; -.
DR   MaxQB; Q9HC77; -.
DR   PaxDb; Q9HC77; -.
DR   PeptideAtlas; Q9HC77; -.
DR   PRIDE; Q9HC77; -.
DR   ProteomicsDB; 63008; -.
DR   ProteomicsDB; 81646; -. [Q9HC77-1]
DR   Antibodypedia; 22520; 183 antibodies.
DR   Ensembl; ENST00000381884; ENSP00000371308; ENSG00000151849. [Q9HC77-1]
DR   Ensembl; ENST00000616936; ENSP00000477511; ENSG00000151849. [Q9HC77-2]
DR   GeneID; 55835; -.
DR   KEGG; hsa:55835; -.
DR   UCSC; uc001upt.6; human. [Q9HC77-1]
DR   CTD; 55835; -.
DR   DisGeNET; 55835; -.
DR   GeneCards; CENPJ; -.
DR   HGNC; HGNC:17272; CENPJ.
DR   HPA; ENSG00000151849; Low tissue specificity.
DR   MalaCards; CENPJ; -.
DR   MIM; 608393; phenotype.
DR   MIM; 609279; gene.
DR   MIM; 613676; phenotype.
DR   neXtProt; NX_Q9HC77; -.
DR   OpenTargets; ENSG00000151849; -.
DR   Orphanet; 2512; Autosomal recessive primary microcephaly.
DR   Orphanet; 808; Seckel syndrome.
DR   PharmGKB; PA26403; -.
DR   VEuPathDB; HostDB:ENSG00000151849.14; -.
DR   eggNOG; ENOG502QQR0; Eukaryota.
DR   GeneTree; ENSGT00530000063927; -.
DR   HOGENOM; CLU_008072_0_0_1; -.
DR   InParanoid; Q9HC77; -.
DR   OMA; EPLNFPD; -.
DR   OrthoDB; 1249457at2759; -.
DR   PhylomeDB; Q9HC77; -.
DR   TreeFam; TF343156; -.
DR   PathwayCommons; Q9HC77; -.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-6804115; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; Q9HC77; -.
DR   BioGRID-ORCS; 55835; 114 hits in 996 CRISPR screens.
DR   ChiTaRS; CENPJ; human.
DR   GeneWiki; CENPJ; -.
DR   GenomeRNAi; 55835; -.
DR   Pharos; Q9HC77; Tbio.
DR   PRO; PR:Q9HC77; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9HC77; protein.
DR   Bgee; ENSG00000151849; Expressed in left lobe of thyroid gland and 205 other tissues.
DR   ExpressionAtlas; Q9HC77; baseline and differential.
DR   Genevisible; Q9HC77; HS.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0008275; C:gamma-tubulin small complex; NAS:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0043015; F:gamma-tubulin binding; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:MGI.
DR   GO; GO:0015631; F:tubulin binding; IDA:UniProtKB.
DR   GO; GO:0030954; P:astral microtubule nucleation; IDA:MGI.
DR   GO; GO:0051301; P:cell division; NAS:UniProtKB.
DR   GO; GO:0061511; P:centriole elongation; IDA:UniProtKB.
DR   GO; GO:0007099; P:centriole replication; IMP:UniProtKB.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0060271; P:cilium assembly; IBA:GO_Central.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0007020; P:microtubule nucleation; TAS:UniProtKB.
DR   GO; GO:0046785; P:microtubule polymerization; IMP:UniProtKB.
DR   GO; GO:1903724; P:positive regulation of centriole elongation; IMP:UniProtKB.
DR   GO; GO:1904951; P:positive regulation of establishment of protein localization; IMP:UniProtKB.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; IDA:MGI.
DR   GO; GO:0046599; P:regulation of centriole replication; IMP:UniProtKB.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   InterPro; IPR033068; CENP-J.
DR   InterPro; IPR009852; Tcp10_C_dom.
DR   InterPro; IPR026581; TCP10_fam.
DR   PANTHER; PTHR10331; PTHR10331; 1.
DR   PANTHER; PTHR10331:SF23; PTHR10331:SF23; 1.
DR   Pfam; PF07202; Tcp10_C; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Cytoskeleton;
KW   Disease variant; Dwarfism; Mental retardation; Microtubule; Phosphoprotein;
KW   Primary microcephaly; Reference proteome.
FT   CHAIN           1..1338
FT                   /note="Centromere protein J"
FT                   /id="PRO_0000089480"
FT   REGION          319..394
FT                   /note="Alpha/beta-tubulin binding"
FT                   /evidence="ECO:0000269|PubMed:19131341"
FT   REGION          895..1338
FT                   /note="Interaction with STIL"
FT                   /evidence="ECO:0000269|PubMed:22020124,
FT                   ECO:0000269|PubMed:25385835"
FT   MOD_RES         260
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         316
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         540
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         589
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:20531387"
FT   MOD_RES         595
FT                   /note="Phosphoserine; by PLK2 and PLK4"
FT                   /evidence="ECO:0000269|PubMed:20531387"
FT   MOD_RES         759
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   VAR_SEQ         1073..1086
FT                   /note="NTSVRFQNSQISSG -> AIHLEDPSLHLLVI (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_056831"
FT   VAR_SEQ         1087..1338
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_056832"
FT   VARIANT         21
FT                   /note="M -> V (in dbSNP:rs35498994)"
FT                   /id="VAR_032427"
FT   VARIANT         55
FT                   /note="P -> A (in dbSNP:rs17081389)"
FT                   /id="VAR_032428"
FT   VARIANT         63
FT                   /note="D -> H (in dbSNP:rs7336216)"
FT                   /id="VAR_032429"
FT   VARIANT         85
FT                   /note="P -> T (in dbSNP:rs9511510)"
FT                   /id="VAR_032430"
FT   VARIANT         151
FT                   /note="E -> G (in dbSNP:rs34177811)"
FT                   /id="VAR_032431"
FT   VARIANT         879
FT                   /note="S -> A (in dbSNP:rs17402892)"
FT                   /id="VAR_032432"
FT   VARIANT         1235
FT                   /note="E -> V (in MCPH6; reduced interaction with STIL;
FT                   dbSNP:rs121434311)"
FT                   /evidence="ECO:0000269|PubMed:15793586,
FT                   ECO:0000269|PubMed:22020124"
FT                   /id="VAR_032433"
FT   MUTAGEN         338
FT                   /note="F->A: Decreases interaction with alpha/beta-tubulin;
FT                   when associated with A-339 and A-341."
FT                   /evidence="ECO:0000269|PubMed:27219064"
FT   MUTAGEN         339
FT                   /note="E->A: Decreases interaction with alpha/beta-tubulin;
FT                   when associated with A-338 and A-341."
FT                   /evidence="ECO:0000269|PubMed:27219064"
FT   MUTAGEN         341
FT                   /note="Y->A: Decreases interaction with alpha/beta-tubulin;
FT                   when associated with A-338 and A-339."
FT                   /evidence="ECO:0000269|PubMed:27219064"
FT   MUTAGEN         343
FT                   /note="E->A: Slightly decreases interaction with
FT                   alpha/beta-tubulin; causes overly long daughter centrioles
FT                   and enhances ciliary length; when associated with A-344."
FT                   /evidence="ECO:0000269|PubMed:27306797"
FT   MUTAGEN         344
FT                   /note="E->A: Slightly decreases interaction with
FT                   alpha/beta-tubulin; causes overly long daughter centrioles
FT                   and enhances ciliary length; when associated with A-343."
FT                   /evidence="ECO:0000269|PubMed:27306797"
FT   MUTAGEN         375
FT                   /note="F->A: Decreases interaction with alpha/beta-tubulin;
FT                   disrupts association with microtubule distal tip; no effect
FT                   on association with microtubule lattice; when associated
FT                   with A-385."
FT                   /evidence="ECO:0000269|PubMed:27219064"
FT   MUTAGEN         375
FT                   /note="F->A: Strongly decreases interaction with
FT                   alpha/beta-tubulin; causes shorter centrioles and doublet
FT                   microtubules in cilia."
FT                   /evidence="ECO:0000269|PubMed:27306797"
FT   MUTAGEN         377
FT                   /note="K->E: Decreases interaction with alpha/beta-tubulin;
FT                   disrupts association with microtubule distal tip; no effect
FT                   on association with microtubule lattice; when associated
FT                   with E-378."
FT                   /evidence="ECO:0000269|PubMed:27219064"
FT   MUTAGEN         378
FT                   /note="R->E: Decreases interaction with alpha/beta-tubulin;
FT                   disrupts association with microtubule distal tip; no effect
FT                   on association with microtubule lattice; when associated
FT                   with E-377."
FT                   /evidence="ECO:0000269|PubMed:27219064"
FT   MUTAGEN         385
FT                   /note="F->A: Decreases interaction with alpha/beta-tubulin;
FT                   disrupts association with microtubule distal tip; no effect
FT                   on association with microtubule lattice; when associated
FT                   with A-375."
FT                   /evidence="ECO:0000269|PubMed:27219064"
FT   MUTAGEN         589
FT                   /note="S->A: Abolishes phosphorylation by PLK2 and
FT                   procentriole formation; when associated with A-595."
FT                   /evidence="ECO:0000269|PubMed:20531387"
FT   MUTAGEN         595
FT                   /note="S->A: Abolishes phosphorylation by PLK2 and
FT                   procentriole formation; when associated with A-589."
FT                   /evidence="ECO:0000269|PubMed:20531387"
FT   CONFLICT        129
FT                   /note="L -> R (in Ref. 1; AAG21074)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1142
FT                   /note="E -> R (in Ref. 7; AAG49440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1224
FT                   /note="L -> W (in Ref. 7; AAG49440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1333
FT                   /note="L -> S (in Ref. 1; AAG21074)"
FT                   /evidence="ECO:0000305"
FT   HELIX           380..385
FT                   /evidence="ECO:0007744|PDB:5EIB"
SQ   SEQUENCE   1338 AA;  153000 MW;  B4E6531B62A30F2D CRC64;
     MFLMPTSSEL NSGQNFLTQW MTNPSRAGVI LNRGFPILEA DKEKRAAVDI STSFPIKGTH
     FSDSFSFINE EDSLLEEQKL ESNNPYKPQS DKSETHTAFP CIKKGPQVAA CHSAPGHQEE
     NKNDFIPDLA SEFKEGAYKD PLFKKLEQLK EVQQKKQEQL KRQQLEQLQR LMEEQEKLLT
     MVSGQCTLPG LSLLPDDQSQ KHRSPGNTTT GERATCCFPS YVYPDPTQEE TYPSNILSHE
     QSNFCRTAHG DFVLTSKRAS PNLFSEAQYQ EAPVEKNNLK EENRNHPTGE SILCWEKVTE
     QIQEANDKNL QKHDDSSEVA NIEERPIKAA IGERKQTFED YLEEQIQLEE QELKQKQLKE
     AEGPLPIKAK PKQPFLKRGE GLARFTNAKS KFQKGKESKL VTNQSTSEDQ PLFKMDRQQL
     QRKTALKNKE LCADNPILKK DSKARTKSGS VTLSQKPKML KCSNRKSLSP SGLKIQTGKK
     CDGQFRDQIK FENKVTSNNK ENVTECPKPC DTGCTGWNKT QGKDRLPLST GPASRLAAKS
     PIRETMKESE SSLDVSLQKK LETWEREKEK ENLELDEFLF LEQAADEISF SSNSSFVLKI
     LERDQQICKG HRMSSTPVKA VPQKTNPADP ISHCNRSEDL DHTAREKESE CEVAPKQLHS
     LSSADELREQ PCKIRKAVQK STSENQTEWN ARDDEGVPNS DSSTDSEEQL DVTIKPSTED
     RERGISSRED SPQVCDDKGP FKDTRTQEDK RRDVDLDLSD KDYSSDESIM ESIKHKVSEP
     SRSSSLSLSK MDFDDERTWT DLEENLCNHD VVLGNESTYG TPQTCYPNNE IGILDKTIKR
     KIAPVKRGED LSKSRRSRSP PTSELMMKFF PSLKPKPKSD SHLGNELKLN ISQDQPPGDN
     ARSQVLREKI IELETEIEKF KAENASLAKL RIERESALEK LRKEIADFEQ QKAKELARIE
     EFKKEEMRKL QKERKVFEKY TTAARTFPDK KEREEIQTLK QQIADLREDL KRKETKWSST
     HSRLRSQIQM LVRENTDLRE EIKVMERFRL DAWKRAEAIE SSLEVEKKDK LANTSVRFQN
     SQISSGTQVE KYKKNYLPMQ GNPPRRSKSA PPRDLGNLDK GQAASPREPL EPLNFPDPEY
     KEEEEDQDIQ GEISHPDGKV EKVYKNGCRV ILFPNGTRKE VSADGKTITV TFFNGDVKQV
     MPDQRVIYYY AAAQTTHTTY PEGLEVLHFS SGQIEKHYPD GRKEITFPDQ TVKNLFPDGQ
     EESIFPDGTI VRVQRDGNKL IEFNNGQREL HTAQFKRREY PDGTVKTVYA NGHQETKYRS
     GRIRVKDKEG NVLMDTEL
//
